Amgen (AMGN) Gross Profit Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
54.44% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
9.77% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
15.45% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-0.16% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
13.38% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
7.57% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-65.16% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-1.22% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
| Mar 31, 2026 |
13.38% |
| Dec 31, 2025 |
194.86% |
| Sep 30, 2025 |
-23.21% |
| Jun 30, 2025 |
76.67% |
| Mar 31, 2025 |
-29.43% |
| Dec 31, 2024 |
17.51% |
| Sep 30, 2024 |
65.43% |
| Jun 30, 2024 |
-0.41% |
| Mar 31, 2024 |
67.43% |
| Dec 31, 2023 |
494.72% |
| Sep 30, 2023 |
0.65% |
| Jun 30, 2023 |
1.75% |
| Mar 31, 2023 |
-6.24% |
| Dec 31, 2022 |
-111.31% |
| Sep 30, 2022 |
-0.65% |
| Jun 30, 2022 |
3.99% |
| Mar 31, 2022 |
6.03% |
| Dec 31, 2021 |
140.41% |
| Sep 30, 2021 |
-20.63% |
| Jun 30, 2021 |
3.62% |
| Mar 31, 2021 |
-5.10% |
| Dec 31, 2020 |
2.36% |
| Sep 30, 2020 |
45.06% |
| Jun 30, 2020 |
3.42% |
| Mar 31, 2020 |
-12.02% |
| Dec 31, 2019 |
-22.74% |
| Sep 30, 2019 |
-14.62% |
| Jun 30, 2019 |
-19.40% |
| Mar 31, 2019 |
-1.07% |
| Dec 31, 2018 |
8.10% |
| Sep 30, 2018 |
0.56% |
| Jun 30, 2018 |
1.65% |
| Mar 31, 2018 |
27.05% |
| Dec 31, 2017 |
-1.95% |
| Sep 30, 2017 |
14.86% |
| Jun 30, 2017 |
25.86% |
| Mar 31, 2017 |
-0.43% |
| Dec 31, 2016 |
-33.01% |
| Sep 30, 2016 |
0.16% |
| Jun 30, 2016 |
6.96% |
| Mar 31, 2016 |
9.89% |
| Dec 31, 2015 |
111.38% |
| Sep 30, 2015 |
18.57% |
| Jun 30, 2015 |
6.93% |
| Mar 31, 2015 |
-11.48% |
| Dec 31, 2014 |
-42.33% |
| Sep 30, 2014 |
-2.05% |
| Jun 30, 2014 |
1.52% |
| Mar 31, 2014 |
4.93% |
| Dec 31, 2013 |
419.13% |
| Sep 30, 2013 |
12.64% |
| Jun 30, 2013 |
10.50% |
| Mar 31, 2013 |
31.23% |
| Dec 31, 2012 |
-55.12% |
| Sep 30, 2012 |
13.33% |
| Jun 30, 2012 |
4.77% |
| Mar 31, 2012 |
3.18% |
| Dec 31, 2011 |
-43.87% |
| Sep 30, 2011 |
-4.70% |
| Jun 30, 2011 |
-8.91% |
| Mar 31, 2011 |
-13.41% |
| Dec 31, 2010 |
1.19% |
| Sep 30, 2010 |
-0.60% |
| Jun 30, 2010 |
0.78% |
| Mar 31, 2010 |
27.74% |